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qDOI of original article: http://dx.doi.org/10.1016/j.fct.2012.08.005We would like to comment on your answers (Hayes, 2014a)
concerning the retraction of our study (Seralini et al., 2012,
Hayes, 2014b) by Food and Chemical Toxicology (FCT). Our study
investigated the long-term effects in rats of consumption of two
Monsanto products, a genetically modiﬁed (GM) maize and its
associated pesticide, Roundup, together and separately. The
decision to retract the paper was reached a few months after the
appointment of a former Monsanto employee as ‘‘editor for
biotechnology’’, a position created for him at FCT (Robinson and
Latham, 2013). In a recent editorial, Portier and colleagues express
concern about the ‘‘dangerous erosion of the underpinnings of the
peer-review process’’ in the case of our study (Portier et al., 2014).
The criticisms from Monsanto and others focused on two
aspects of our study: the relatively low number of rats used
compared with the 50 per sex per group usual for carcinogenicity
studies (OECD, 2009a) and the strain of rat used, the Sprague–
Dawley. The critics alleged that the Sprague–Dawley rat was prone
to tumours and that therefore the increased rate of tumorigenesis
found in some of our treatment groups was purely random, even if
this strain is commonly used in toxicology. Other answers to critics
have been already published (Seralini et al., 2013).
These criticisms were subsequently adopted in your statement
explaining the decision to retract our study. You wrote that the low
number of rats and the strain selected meant that the conclusions
on two aspects of our study – mortality and tumorigenesis – were
‘‘inconclusive’’ (Hayes, 2014a). In addition, you attested that our
raw data were ‘‘not incorrect’’, ‘‘there was no misconduct’’, and that
‘‘Unequivocally, the Editor-in-Chief found no evidence of fraud or
intentional misrepresentation of the data’’ (Seralini et al., 2014).
We are sceptical about the rationale given to retract our paper,
in light of FCT’s recent publication of another study (Zhang et al.,
2014) which, like ours, investigated the potential chronic effects
of consumption of a genetically modiﬁed (GM) crop. Unlike our
study, however, it concluded that the GM crop tested, a transgenic
insecticide-producing rice, was as safe and nutritious as conven-
tional rice. Yet according to your criteria, it is at least as inconclusive
as our study. Thus, it should not be published. Double standards
are clearly used in evaluating Seralini et al. (2012), Hayes
(2014b) and Zhang et al. (2014) in FCT.
Zhang et al. (2014) reached their conclusion of safety on the
basis of only one treated group fed with the GMO, which they
compared with two control groups, which can also bias the conclu-
sion. Though 30 Sprague–Dawley rats were used per group, only 10
were measured for serum biochemistry, the same number as in our
study.In contrast with our study, Zhang and colleagues performed
anatomopathology on an interim group of 10 rats analyzed at
52 weeks, though the results are not detailed in the paper. Zhang
and colleagues also measured the mortality and tumour incidence
of the remaining rats at the end of the experiment. This omits the
chronological data provided in our experiment, in which the differ-
ential development of tumours in the treatment groups was traced
through bi-weekly recording.
The criticism of the relatively low number of rats used in
our experiment relies entirely on the misconception that it is a
carcinogenicity study. It was not the case, as we stated clearly in
the title and introduction. It was a long-term (chronic) toxicity
study, which unexpectedly found increased rates of tumorigenesis
and mortality in some treatment groups that we had to report.
The protocol set by the Organisation for Economic Cooperation
and Development (OECD) for carcinogenicity studies on chemicals
requires at least 50 animals per sex per group (OECD, 2009a). This
large number of rats is intended to increase the ‘‘sensitivity’’ of the
study (OECD, 2012), thereby protecting from false negative error,
in which a carcinogenic effect exists but is missed because the
number of rats used is too low to be representative of a population,
or from false positive errors. Another reason for the large number
of rats is that the background rate of so-called ‘‘spontaneous’’
tumours in laboratory rodents requires the use of large groups in
order to reach statistical signiﬁcance. The high background of
tumors in historical data has not yet been proven as spontaneous,
since the regulatory feed throughout the world may be contami-
nated with levels of GMOs and pesticides by contrast to our
controls. Only the comparisons to the internal control are relevant.
External controls, often called historical data, are irrelevant
because the rats were raised in different conditions and may be
subject to different feed contaminations even between different
batches of the same brand of feed.
The number of rats we used was appropriate for a chronic tox-
icity study, as conﬁrmed by the OECD chronic toxicity protocol,
which speciﬁes 20 animals per sex per group but only requires that
50% – 10 per sex per group – be analyzed for blood and clinical
chemistry. This is also the same number that Zhang and colleagues
analyzed. Thus regarding the number of rats, our study was equiv-
alent to that of Zhang and colleagues and consistent with the ana-
lytical requirements of the OECD. In addition, the OECD chronic
toxicity protocol 452 speciﬁes that any ‘‘lesions’’ (the deﬁnition
would include tumours) must be recorded (OECD, 2009b). This
exactly reﬂects our practice.
In fact you clariﬁed your position in a statement published in
FCT: ‘‘To be very clear, it is the entire paper, with the claim that
there is deﬁnitive link between GMO and cancer that is being
retracted’’ (Hayes, 2014a). Yet we made no such ‘‘claim’’ in our
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nowhere did we claim a ‘‘deﬁnitive link between GMO and cancer’’.
In fact, our entire paper does not even mention the word ‘‘cancer’’.
It should be noted that tumorigenesis is not synonymous with
cancer. Tumours can be in some cases more rapidly lethal than
cancers because their size can cause hemorrhages and possible
impairments of vital organs, as well as secretion of toxins.
Your statement indicates that the retraction is based on confu-
sion and over-generalization. The confusion, as indicated above,
lies in the failure to understand that our study is about ‘‘long-term
toxicity’’, not ‘‘cancer’’. Not surprisingly therefore, our study does
not follow a carcinogenicity experimental protocol, which should
be performed after a broadly focused long-term toxicity study such
as ours.
Moreover, the stated reason for the retraction, the ‘‘inconclu-
sive’’ nature of the tumours and mortality ﬁndings (Hayes,
2014a), does not equate to ‘‘error’’. Lack of conclusiveness and
error are not synonymous.
Concerning over-generalization, contrary to your claim, the
‘‘entire paper’’ is not focused on the issue of tumours. The main
part of the paper presents measurements of numerous biological
parameters pertaining to the function of multiple organ systems,
the statistical analysis and signiﬁcance of which have not been
challenged. Even if our paper had not mentioned the early appear-
ance of tumours and premature deaths in rats, the chronic toxicity
ﬁndings alone would justify its presence in the scientiﬁc record.
These include effects on the disturbances of sex hormones and
severe dysfunctions in liver and kidneys. Moreover, our study rep-
resents the only study on Roundup that includes blood analyses of
treated animals (and from very low environmental levels, 0.1 ppb),
since regulatory agencies only have chronic data with glyphosate
used alone (Mortureux, 2013), which is highly less toxic than
Roundup (Mesnage et al., 2013; Richard et al., 2005). Such analyses
have never been conducted on the complete herbicide formulation
for regulatory purposes.
A second rat feeding study with a GM crop, also published in
FCT (Hammond et al., 2004) and also not retracted, also raises
questions about double standards. This was a 90-day subchronic
rat feeding study by Monsanto authors, examining the same GM
maize that we tested over a chronic two-year period. In spite of
the short duration, the Monsanto study still found differences in
multiple organ functions between the GM and non-GM feeding
groups. However, the authors dismissed them as not ‘‘biologically
meaningful’’.
We have obtained the raw data of this study through a court
case and re-analyzed the Monsanto data. We found potential signs
of liver and kidney toxicity in rats fed NK603 maize (Spiroux de
Vendômois et al., 2009). Our later study (Seralini et al., 2012,
Hayes, 2014b) was designed to mirror the Monsanto study design
and ﬁnd out whether these initial signs of toxicity were really bio-
logically irrelevant, as the Monsanto authors claimed, or escalated
into serious pathology. We found that the latter was the case.
We conclude from this series of events that Hammond et al.
(2004) was ‘‘inconclusive’’, in that changes were noticed in the
GM feeding groups, but their signiﬁcance was unclear because of
the short subchronic study duration. Our study was the ﬁrst and
only attempt to clarify these inconclusive ﬁndings by extending
the study length. Other researchers, including those working for
Monsanto, are invited in turn to clarify the less ‘‘conclusive’’
aspects or our research: for example, by performing a large-scale
carcinogenicity study.
A recent review (Meyer and Hilbeck, 2013) comparing our
study with Hammond et al. (2004) and EFSA release of Monsanto’s
data on the same GM maize conﬁrms our view that double stan-
dards were applied to reject our study alone. In this case, the bodyfound to apply the double standard was not the editor of a journal
but the European Food Safety Authority (EFSA).
Meyer and Hilbeck applied the same criteria used by EFSA to
reject our study to the Monsanto conclusions, which were used
to support regulatory authorization. They found that all three stud-
ies satisﬁed or failed to satisfy EFSA’s criteria to a comparable
extent, but that only our study was rejected by EFSA. In fact, EFSA
did not even apply its criteria to Monsanto’s studies. The authors
also found that EFSA’s criteria did not reﬂect standard practice in
21 other rat feeding studies of 12 months duration or longer, none
of which have been retracted.
FCT’s retraction of our paper, while not retracting studies –
Zhang et al. (2014) and Hammond et al. (2004) – is an example
of unscientiﬁc double standards. The decision to retract our paper
appears to be results-driven, in that ﬁndings of safety in Zhang
et al. (2014) and Hammond et al. (2004) have not been subjected
to critical analysis and have been allowed to stand, whereas our
ﬁndings of risk have been viewed with suspicion and forcibly
retracted. As a result, economic interests have been given prece-
dence over public health.
The use of double standards by the editors of scientiﬁc journals
in evaluating studies on matters important to public health will
damage the image and the value of science.Conﬂict of Interest
The authors declare that there are no conﬂicts of interest.References
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